Page last updated: 2024-08-23

cabergoline and Hypergonadotropic Hypogonadism

cabergoline has been researched along with Hypergonadotropic Hypogonadism in 16 studies

Research

Studies (16)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (6.25)	18.2507
2000's	4 (25.00)	29.6817
2010's	7 (43.75)	24.3611
2020's	4 (25.00)	2.80

Authors

Authors	Studies
Akirov, A; Duskin-Bitan, H; Masri-Iraqi, H; Rudman, Y; Shimon, I	1
Auriemma, RS; Colao, A; Garifalos, F; Pirchio, R; Pivonello, C; Pivonello, R	1
Duskin-Bitan, H; Shimon, I	1
Bandgar, T; Jaiswal, SK; Lila, AR; Patil, V; Ramteke-Jadhav, S; Sankhe, S; Sarathi, V; Sehemby, M; Shah, N; Shah, R	1
Chia, YY; Goh, GH; Mohan, N; Teo, K; Ting, E; Yeo, TT	1
Benbassat, C; Shimon, I	1
D'Sylva, C; Fraser, LA; Khan, T; Van Uum, S	1
Chapman, IM; De Sousa, SM; Falhammar, H; Torpy, DJ	1
Burri, E; Nüesch, R; Zulewski, H	1
Conaglen, HM; Conaglen, JV	1
Benbassat, C; Grozinsky-Glasberg, S; Shimon, I; Tzvetov, G	1
Díez, JJ; Iglesias, P	1
Chatziioannou, S; Filippopoulou, A; Lykouras, L; Peppa, M; Rizos, E; Tsigkaropoulou, E; Xelioti, I; Zompola, C	1
Christ, ER; Jenni, S; Seiler, R; Stettler, C	1
Webster, J	1
Tollin, SR	1

Reviews

4 review(s) available for cabergoline and Hypergonadotropic Hypogonadism

Article	Year
Approach to the Patient With Prolactinoma. The Journal of clinical endocrinology and metabolism, 2023, 08-18, Volume: 108, Issue:9 Topics: Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hypogonadism; Male; Pituitary Neoplasms; Pregnancy; Prolactin; Prolactinoma	2023
Prolactinomas in males: any differences? Pituitary, 2020, Volume: 23, Issue:1 Topics: Cabergoline; Dopamine Agonists; Humans; Hypogonadism; Male; Pituitary Neoplasms; Prolactinoma; Somatostatin; Temozolomide	2020
Osteoporotic fractures in patients with untreated hyperprolactinemia vs. those taking dopamine agonists: A systematic review and meta-analysis. Neuro endocrinology letters, 2015, Volume: 36, Issue:8 Topics: Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Hypogonadism; Male; Odds Ratio; Osteoporotic Fractures; Pituitary Neoplasms; Prevalence; Prolactinoma; Sex Factors; Spinal Fractures	2015
Clinical management of prolactinomas. Bailliere's best practice & research. Clinical endocrinology & metabolism, 1999, Volume: 13, Issue:3 Topics: Bone Density; Cabergoline; Dopamine Agonists; Drug Resistance; Ergolines; Female; Humans; Hypogonadism; Male; Pituitary Neoplasms; Pregnancy; Prolactinoma	1999

Other Studies

12 other study(ies) available for cabergoline and Hypergonadotropic Hypogonadism

Article	Year
Predicting hypogonadotropic hypogonadism persistence in male macroprolactinoma. Pituitary, 2022, Volume: 25, Issue:6 Topics: Adult; Cabergoline; Humans; Hypogonadism; Hypopituitarism; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Retrospective Studies; Testosterone	2022
Predictors of Chronic LH-Testosterone Axis Suppression in Male Macroprolactinomas With Normoprolactinemia on Cabergoline. The Journal of clinical endocrinology and metabolism, 2020, 12-01, Volume: 105, Issue:12 Topics: Adult; Cabergoline; Cross-Sectional Studies; Down-Regulation; Humans; Hypogonadism; Luteinizing Hormone; Male; Middle Aged; Pituitary Neoplasms; Prognosis; Prolactin; Prolactinoma; Prospective Studies; Remission Induction; Retrospective Studies; Signal Transduction; Testosterone; Treatment Outcome; Young Adult	2020
Cabergoline-induced fibrosis of prolactinomas: a neurosurgical perspective. BMJ case reports, 2017, Nov-03, Volume: 2017 Topics: Adult; Antineoplastic Agents; Cabergoline; Combined Modality Therapy; Diagnosis, Differential; Dopamine Agonists; Ergolines; Fibrosis; Humans; Hypogonadism; Hypothyroidism; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Prolactinoma; Thyroxine; Tricuspid Valve Insufficiency	2017
Male prolactinomas presenting with normal testosterone levels. Pituitary, 2014, Volume: 17, Issue:3 Topics: Adult; Aged; Antineoplastic Agents; Cabergoline; Cohort Studies; Ergolines; Humans; Hypogonadism; Male; Middle Aged; Pituitary Neoplasms; Prognosis; Prolactinoma; Testosterone; Treatment Outcome	2014
Dopa-testotoxicosis: disruptive hypersexuality in hypogonadal men with prolactinomas treated with dopamine agonists. Endocrine, 2017, Volume: 55, Issue:2 Topics: Adult; Aged; Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Humans; Hypogonadism; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Retrospective Studies; Sexual Dysfunction, Physiological	2017
[Hyperprolactinemia in a man's world]. Praxis, 2008, Dec-03, Volume: 97, Issue:24 Topics: Algorithms; Cabergoline; Diagnosis, Differential; Dopamine Agonists; Ergolines; Follow-Up Studies; Gynecomastia; Humans; Hyperprolactinemia; Hypogonadism; Male; Middle Aged; Prolactin; Testosterone; Time Factors; Ultrasonography, Mammary	2008
The effects of treating male hypogonadism on couples' sexual desire and function. The journal of sexual medicine, 2009, Volume: 6, Issue:2 Topics: Adult; Aged; Cabergoline; Dopamine Agonists; Ergolines; Female; Hormone Replacement Therapy; Humans; Hypogonadism; Male; Middle Aged; Personal Satisfaction; Sexual Dysfunctions, Psychological; Surveys and Questionnaires; Testosterone	2009
Anemia in a cohort of men with macroprolactinomas: increase in hemoglobin levels follows prolactin suppression. Pituitary, 2011, Volume: 14, Issue:1 Topics: Adenoma; Adult; Aged; Antineoplastic Agents; Cabergoline; Ergolines; Hemoglobins; Humans; Hypogonadism; Male; Middle Aged; Prolactin; Prolactinoma; Retrospective Studies; Testosterone	2011
Chronic anemia as first clinical manifestation of a prolactin-secreting pituitary macroadenoma in a male patient. The American journal of medicine, 2011, Volume: 124, Issue:6 Topics: Anemia; Antineoplastic Agents; Biomarkers, Tumor; Cabergoline; Chronic Disease; Dopamine Agonists; Drug Therapy, Combination; Early Detection of Cancer; Ergolines; Hematocrit; Hemoglobins; Hormone Replacement Therapy; Humans; Hydrocortisone; Hypogonadism; Hypopituitarism; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Testosterone; Thyroxine; Treatment Outcome	2011
Hypogonadism due to hyperprolactinemia and subsequent first episode of psychosis. Gender medicine, 2012, Volume: 9, Issue:1 Topics: Adult; Antipsychotic Agents; Aripiprazole; Cabergoline; Ergolines; Humans; Hyperprolactinemia; Hypogonadism; Male; Obesity, Morbid; Piperazines; Pituitary Neoplasms; Prolactin; Prolactinoma; Psychotic Disorders; Quinolones; Schizophrenia	2012
[Simultaneous defect of visual fields and loss of libido--a coincidence?]. Praxis, 2006, Dec-06, Volume: 95, Issue:49 Topics: Cabergoline; Diagnosis, Differential; Dopamine Agonists; Erectile Dysfunction; Ergolines; Humans; Hyperprolactinemia; Hypogonadism; Libido; Magnetic Resonance Imaging; Male; Middle Aged; Nerve Compression Syndromes; Optic Nerve Diseases; Pituitary Neoplasms; Prolactinoma; Visual Fields	2006
Use of the dopamine agonists bromocriptine and cabergoline in the management of risperidone-induced hyperprolactinemia in patients with psychotic disorders. Journal of endocrinological investigation, 2000, Volume: 23, Issue:11 Topics: Adult; Antipsychotic Agents; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Hypogonadism; Male; Middle Aged; Prolactin; Psychotic Disorders; Risperidone	2000